Periapical status transitions in teeth with posts versus without posts: a retrospective longitudinal radiographic study.


Journal

Acta odontologica Scandinavica
ISSN: 1502-3850
Titre abrégé: Acta Odontol Scand
Pays: England
ID NLM: 0370344

Informations de publication

Date de publication:
Nov 2022
Historique:
pubmed: 31 3 2022
medline: 22 10 2022
entrez: 30 3 2022
Statut: ppublish

Résumé

The aim of this study was to compare periapical status transitions in teeth after post placement compared with other post-endodontic treatments in root-filled teeth. This retrospective longitudinal radiographic study included radiographs of 284 patients with root filled and restored teeth with composite fillings (Endo-fill group, Of 284 root-filled teeth without apical periodontitis at baseline, 7.7% developed clear apical pathology within a minimum of 8 months observational period. In the Endo-post group 11 (10.78%) teeth transited from Healthy (PAI 1) to Disease (PAI 2-4) state compared with eight (9.75%) in the Endo-crown group and four (4%) in the Endo-fill group. The transition probabilities from Healthy (PAI 1) to Mild diseased (PAI 2) were 17.5% in the Endo-post group, 13.1% in the Endo-crown group and 5.3% in the Endo-fill group. Multivariate analysis showed that teeth in the Endo-fill group had 60% lower hazard to transit from Healthy (PAI 1) to Mild diseased (PAI 2) state [HR 0.40; 95% CI 0.12, 0.94]. A period exceeding 8 months between the end of the endodontic treatment and prosthetic treatment significantly increased the hazard of disease progression by three times compared with a period of ≤8 months [HR 3.16; 95% CI 1.06, 9.42]. Teeth without radiographic lesions at baseline and restored with posts had higher hazard to transit from healthy to diseased periapical status compared with teeth restored with composite restorations. Controlled clinical trials with longer follow-up periods are needed to validate these findings.

Identifiants

pubmed: 35350966
doi: 10.1080/00016357.2022.2049865
doi:

Substances chimiques

Gold Alloys 0
Plasminogen Activator Inhibitor 1 0
Plasminogen Activator Inhibitor 2 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

561-568

Auteurs

Marika Koutsouri Haereid (MK)

Department of Prosthodontics, Institute of Clinical Dentistry, University of Oslo, Oslo, Norway.

Lina Stangvaltaite-Mouhat (L)

Oral Health Centre of Expertise in Eastern Norway (OHCE-E), Oslo, Norway.

Vibeke Ansteinsson (V)

Oral Health Centre of Expertise in Eastern Norway (OHCE-E), Oslo, Norway.

Ibrahimu Mdala (I)

Oral Health Centre of Expertise in Eastern Norway (OHCE-E), Oslo, Norway.

Dag Ørstavik (D)

Department of Endodontics, Institute of Clinical Dentistry, University of Oslo, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH